Literature DB >> 11992772

A novel type of nonsteroidal estrone sulfatase inhibitors.

Peter Jütten1, Winfried Schumann, Albert Härtl, Lothar Heinisch, Udo Gräfe, Walter Werner, Hermann Ulbricht.   

Abstract

Madurahydroxylactone (MHL) is a secondary metabolite produced by the soil bacterium Nonomuria rubra and belongs to the family of benzo[a]naphthacenequinones. We report the initial results and structure-activity relationships of our study into a series of thiosemicarbazone derivatives of madurahydroxylactone as potential nonsteroidal inhibitors of the enzyme estrone sulfatase. The most active compound, the cyclohexylthiosemicarbazone, was shown to be a non-competitive inhibitor with a K(i) of 0.35microM. This compound is devoid of estrogenic properties and showed low acute toxicity in the hen's fertile egg screening test.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11992772     DOI: 10.1016/s0960-894x(02)00171-3

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

1.  Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes.

Authors:  Tahmeena Khan; Shalini Dixit; Rumana Ahmad; Saman Raza; Iqbal Azad; Seema Joshi; Abdul Rahman Khan
Journal:  J Chem Biol       Date:  2017-04-04

2.  Madurahydroxylactone derivatives as dual inhibitors of human immunodeficiency virus type 1 integrase and RNase H.

Authors:  Christophe Marchand; John A Beutler; Antony Wamiru; Scott Budihas; Ute Möllmann; Lothar Heinisch; John W Mellors; Stuart F Le Grice; Yves Pommier
Journal:  Antimicrob Agents Chemother       Date:  2007-10-29       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.